SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Hallucinogen-Induced UP States in the Brain Slice of Rat Prefrontal Cortex: Role of Glutamate Spillover and NR2B-NMDA Receptors
5 references·2 citing·26 second hop
Hallucinogen-Induced UP States in the Brain Slice of Rat Prefrontal Cortex: Role of Glutamate Spillover and NR2B-NMDA Receptors (2005)Hallucinogen-Induced UP States in the Bra…Lysergic acid diethylamide and [−]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex (2004)Lysergic acid diethylamide an…Hallucinogens (2004)HallucinogensThe hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats (2003)The hallucinogen 1-[2,5-dimet…Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDG (1999)Neurometabolic Effects of Psi…Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis (1997)Positron Emission Tomography …A unified model of ketamine’s dissociative and psychedelic properties (2022)A unified model of ketamine’s…Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia (2014)Chronic LSD alters gene expre…Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)PIHKAL: A Chemical Love Story (1991)Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Effect of Hallucinogens on Unconditioned Behavior (2016)d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders (2018)Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior (2022)Galaxy: A platform for interactive large-scale genome analysis (2005)Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders (2010)Psychedelics as a Treatment for Alzheimer’s Disease Dementia (2020)Psychedelic‐inspired approaches for treating neurodegenerative disorders (2021)Serotonin and Hallucinogens (1999)Das State-Trait-Angstinventar (STAI) : theoretische Grundlagen und Handanweisung (1981)Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking (2016)Models of psychedelic drug action: modulation of cortical-subcortical circuits (2021)Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review (2022)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psychedelics (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers (1998)Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens (2011)Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects (2014)Human hallucinogen research: guidelines for safety (2008)Psychedelics Promote Structural and Functional Neural Plasticity (2018)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)
this work references cited by second hop

References

  • 2004Hallucinogens1,208 cited
  • 1997Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis444 cited
  • 1999Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDG219 cited
  • 2003The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats126 cited
  • 2004Lysergic acid diethylamide and [−]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex119 cited

Cited by

  • 2014Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia67 cited
  • 2022A unified model of ketamine’s dissociative and psychedelic properties65 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work